Impact of implementing a Choosing Wisely educational intervention into clinical practice: The CW-SIMI study (a multicenter-controlled study)

Eur J Intern Med. 2021 Nov:93:71-77. doi: 10.1016/j.ejim.2021.07.008. Epub 2021 Aug 2.

Abstract

Objectives: To evaluate the impact of an educational intervention based on the Italian Society of Internal Medicine Choosing Wisely (CW-SIMI) recommendations.

Design: Multicenter, interventional, controlled study.

Setting: Twenty-three acute-care hospital wards in Italy.

Participants: 303 Physicians working in internal medicine wards.

Intervention: An online educational course.

Main outcomes: The rate of proton pump inhibitor (PPI) prescriptions, the number of days of central venous catheter (CVC) usage, and the duration of intravenous (IV) antibiotic prescriptions evaluated at one month (T1) and at six months (T2) after course completion. Patients admitted and discharged during a 30-day period before the educational intervention (T0, one year before T2) were considered the comparison group.

Results: A total of 232 physicians completed the course, while 71 did not attend the course. Data from 608, 662, and 555 patients were analyzed at T0, T1, and T2, respectively. The rate of PPI prescriptions declined at one month (RR: 0.67, 95% CI: 0.52-0.87, p = 0.0005) and at six months (RR: 0.62, 95% CI: 0.46-0.84, p = 0.003), and the number of days of CVC usage was reduced at six months (9.13 days at T0 vs. 5.52 days at T2, p = 0.007). The duration of IV antibiotic prescriptions displayed a decreasing trend (7.94 days at T0 vs. 7.42 days at T2, p = 0.081).

Conclusions: A simple online educational intervention based on the CW-SIMI recommendations was associated with a clinically relevant reduction in the usage of PPIs and CVCs. Further studies are needed to confirm these findings and a possible benefit on patients' outcomes.

Keywords: Antibiotics; Appropriateness; Choosing wisely; Cvc; Less is more; Proton pump inhibitors.

Publication types

  • Multicenter Study

MeSH terms

  • Administration, Intravenous
  • Anti-Bacterial Agents* / therapeutic use
  • Humans
  • Internal Medicine
  • Italy
  • Proton Pump Inhibitors* / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Proton Pump Inhibitors